Acadia Pharmaceuticals buy Citigroup Inc.
Start price
08.08.24
/
50%
€14.56
Target price
08.08.25
€21.06
Performance (%)
43.94%
End price
09.08.25
€20.95
Summary
This prediction ended on 09.08.25 with a price of €20.95. With a performance of 43.94% the BUY prediction by Citigroup_Inc_ was a big success. Citigroup_Inc_ has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 7.903% | 7.903% | 12.191% |
| iShares Core DAX® | 0.024% | 0.583% | 11.674% |
| iShares Nasdaq 100 | 1.740% | -2.061% | 4.180% |
| iShares Nikkei 225® | 0.428% | 10.487% | 29.994% |
| iShares S&P 500 | 1.329% | 0.140% | 3.333% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
8.26%
10.05.25
10.05.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-17.60%
14.12.24
14.12.24